| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |